ESMO Investigator Insights | Professor Quchang Ouyang: Deep Tumor Shrinkage and a Manageable Safety Profile — Iza-bren Ushers in a New Era of Bispecific ADC Therapy for Breast Cancer
The annual meeting of the European Society for Medical Oncology (ESMO) is one of the most authoritative academic gatherings in global oncology. The presentation of key research findings continues to drive advances in clinical practice and reshape treatment paradigms. At the 2026 ESMO Congress, the PANKU-Breast01 study, led by Academician Binghe Xu of the Chinese Academy of Engineering and the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, was presented as a Late-breaking Abstract (LBA).









